{"pmid":32434211,"title":"Viral and host factors related to the clinical outcome of COVID-19.","text":["Viral and host factors related to the clinical outcome of COVID-19.","In December 2019, the Coronavirus disease 2019 (COVID-19), caused by a novel coronavirus SARS-CoV-2, emerged in Wuhan, Hubei province, China(1) and soon spread across the world. In this ongoing pandemic, public health concerns and the urgent need for effective therapeutic measures require a deep understanding of its epidemiology, transmissibility and pathogenesis. Here we analyzed the clinical, molecular and immunological data from 326 confirmed cases of COVID-19 in Shanghai. Genomic sequences of SARS-CoV-2 assembled from 112 quality samples together with sequences in the Global Initiative on Sharing All Influenza Data (GISAID) showed a stable evolution and suggested two major lineages with differential exposure history during the early phase of the outbreak in Wuhan. Nevertheless, they exhibited similar virulence and clinical outcomes. Lymphocytopenia, especially the reduced CD4(+) and CD8(+) T cell counts upon admission, was predictive of disease progression. High levels of IL-6 and IL-8 during treatment were observed in patients with severe or critical disease and correlated with decreased lymphocyte count. The determinants of disease severity seemed to stem mostly from host factors such as age, lymphocytopenia, and its associated cytokine storm, whereas viral genetic variation did not significantly affect the outcomes.","Nature","Zhang, Xiaonan","Tan, Yun","Ling, Yun","Lu, Gang","Liu, Feng","Yi, Zhigang","Jia, Xiaofang","Wu, Min","Shi, Bisheng","Xu, Shuibao","Chen, Jun","Wang, Wei","Chen, Bing","Jiang, Lu","Yu, Shuting","Lu, Jing","Wang, Jinzeng","Xu, Mingzhu","Yuan, Zhenghong","Zhang, Qin","Zhang, Xinxin","Zhao, Guoping","Wang, Shengyue","Chen, Saijuan","Lu, Hongzhou","32434211"],"abstract":["In December 2019, the Coronavirus disease 2019 (COVID-19), caused by a novel coronavirus SARS-CoV-2, emerged in Wuhan, Hubei province, China(1) and soon spread across the world. In this ongoing pandemic, public health concerns and the urgent need for effective therapeutic measures require a deep understanding of its epidemiology, transmissibility and pathogenesis. Here we analyzed the clinical, molecular and immunological data from 326 confirmed cases of COVID-19 in Shanghai. Genomic sequences of SARS-CoV-2 assembled from 112 quality samples together with sequences in the Global Initiative on Sharing All Influenza Data (GISAID) showed a stable evolution and suggested two major lineages with differential exposure history during the early phase of the outbreak in Wuhan. Nevertheless, they exhibited similar virulence and clinical outcomes. Lymphocytopenia, especially the reduced CD4(+) and CD8(+) T cell counts upon admission, was predictive of disease progression. High levels of IL-6 and IL-8 during treatment were observed in patients with severe or critical disease and correlated with decreased lymphocyte count. The determinants of disease severity seemed to stem mostly from host factors such as age, lymphocytopenia, and its associated cytokine storm, whereas viral genetic variation did not significantly affect the outcomes."],"journal":"Nature","authors":["Zhang, Xiaonan","Tan, Yun","Ling, Yun","Lu, Gang","Liu, Feng","Yi, Zhigang","Jia, Xiaofang","Wu, Min","Shi, Bisheng","Xu, Shuibao","Chen, Jun","Wang, Wei","Chen, Bing","Jiang, Lu","Yu, Shuting","Lu, Jing","Wang, Jinzeng","Xu, Mingzhu","Yuan, Zhenghong","Zhang, Qin","Zhang, Xinxin","Zhao, Guoping","Wang, Shengyue","Chen, Saijuan","Lu, Hongzhou"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32434211","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1038/s41586-020-2355-0","locations":["Wuhan","Hubei","Shanghai","Wuhan","Lymphocytopenia","lymphocytopenia"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1667342288242606081,"score":9.490897,"similar":[{"pmid":32479985,"pmcid":"PMC7256549","title":"Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.","text":["Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.","The lymphopenia exhibited in patients with COVID-19 has been associated with a worse prognosis in the development of the disease. To understand the factors associated with a worse evolution of COVID-19, we analyzed comorbidities, indicators of inflammation such as CRP and the ratio of neutrophils/lymphocytes, as well as the count of blood cells with T-lymphocyte subtypes in 172 hospitalized patients with COVID-19 pneumonia. Patients were grouped according to their needs for mechanical ventilation (ICU care) or not. Within the comorbidities studied, obesity was the only associated with greater severity and ICU admission. Both the percentage and the absolute number of neutrophils were higher in patients needing ICU care than non-ICU patients, whereas absolute lymphocyte count, and especially the percentage of lymphocytes, presented a deep decline in critical patients. There was no difference between the two groups of patients for CD4 T-lymphocytes, neither in percentage of lymphocyte nor in absolute number, however for CD8 T-cells the differences were significant for both parameters which were in decline in ICU patients. There was a firm correlation between the highest values of inflammation indicators with the decrease in percentage of CD8 T-lymphocytes. This effect was not seen with CD4 cells. Obesity together with lymphopenia, especially whether preferentially affects to CD8 T- lymphocytes, are factors that can predict a poor prognosis in patients with COVID-19.","Clin Immunol","Urra, J M","Cabrera, C M","Porras, L","Rodenas, I","32479985"],"abstract":["The lymphopenia exhibited in patients with COVID-19 has been associated with a worse prognosis in the development of the disease. To understand the factors associated with a worse evolution of COVID-19, we analyzed comorbidities, indicators of inflammation such as CRP and the ratio of neutrophils/lymphocytes, as well as the count of blood cells with T-lymphocyte subtypes in 172 hospitalized patients with COVID-19 pneumonia. Patients were grouped according to their needs for mechanical ventilation (ICU care) or not. Within the comorbidities studied, obesity was the only associated with greater severity and ICU admission. Both the percentage and the absolute number of neutrophils were higher in patients needing ICU care than non-ICU patients, whereas absolute lymphocyte count, and especially the percentage of lymphocytes, presented a deep decline in critical patients. There was no difference between the two groups of patients for CD4 T-lymphocytes, neither in percentage of lymphocyte nor in absolute number, however for CD8 T-cells the differences were significant for both parameters which were in decline in ICU patients. There was a firm correlation between the highest values of inflammation indicators with the decrease in percentage of CD8 T-lymphocytes. This effect was not seen with CD4 cells. Obesity together with lymphopenia, especially whether preferentially affects to CD8 T- lymphocytes, are factors that can predict a poor prognosis in patients with COVID-19."],"journal":"Clin Immunol","authors":["Urra, J M","Cabrera, C M","Porras, L","Rodenas, I"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32479985","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.clim.2020.108486","topics":["Treatment","Mechanism","Diagnosis"],"weight":1,"_version_":1668532089484476416,"score":176.21071},{"pmid":32466577,"title":"Early Phylogenetic Diversification of SARS-CoV-2: Determination of Variants and the Effect on Epidemiology, Immunology, and Diagnostics.","text":["Early Phylogenetic Diversification of SARS-CoV-2: Determination of Variants and the Effect on Epidemiology, Immunology, and Diagnostics.","The phylogenetic clustering of 95 SARS-CoV-2 sequences from the first 3 months of the pandemic reveals insights into the early evolution of the virus and gives first indications of how the variants are globally distributed. Variants might become a challenge in terms of diagnostics, immunology, and effectiveness of drugs. All available whole genome sequence data from the NCBI database (March 16, 2020) were phylogenetically analyzed, and gene prediction as well as analysis of selected variants were performed. Antigenic regions and the secondary protein structure were predicted for selected variants. While some clusters are presenting the same variant with 100% identical bases, other SARS-CoV-2 lineages show a beginning diversification and phylogenetic clustering due to base substitutions and deletions in the genomes. First molecular epidemiological investigations are possible with the results by adding metadata as travelling history to the presented data. The advantage of variants in source tracing can be a challenge in terms of virulence, immune response, and immunological memory. Variants of viruses often show differences in virulence or antigenicity. This must also be considered in decisions like herd immunity. Diagnostic methods might not work if the variations or deletions are in target regions for the detection of the pathogen. One base substitution was detected in a primer binding site.","J Clin Med","Kaden, Rene","32466577"],"abstract":["The phylogenetic clustering of 95 SARS-CoV-2 sequences from the first 3 months of the pandemic reveals insights into the early evolution of the virus and gives first indications of how the variants are globally distributed. Variants might become a challenge in terms of diagnostics, immunology, and effectiveness of drugs. All available whole genome sequence data from the NCBI database (March 16, 2020) were phylogenetically analyzed, and gene prediction as well as analysis of selected variants were performed. Antigenic regions and the secondary protein structure were predicted for selected variants. While some clusters are presenting the same variant with 100% identical bases, other SARS-CoV-2 lineages show a beginning diversification and phylogenetic clustering due to base substitutions and deletions in the genomes. First molecular epidemiological investigations are possible with the results by adding metadata as travelling history to the presented data. The advantage of variants in source tracing can be a challenge in terms of virulence, immune response, and immunological memory. Variants of viruses often show differences in virulence or antigenicity. This must also be considered in decisions like herd immunity. Diagnostic methods might not work if the variations or deletions are in target regions for the detection of the pathogen. One base substitution was detected in a primer binding site."],"journal":"J Clin Med","authors":["Kaden, Rene"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32466577","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3390/jcm9061615","keywords":["covid-19","sars-cov-2","molecular epidemiology","virus variant detection"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1668167110068535296,"score":156.18425},{"pmid":32399213,"pmcid":"PMC7211507","title":"Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence.","text":["Dynamics of peripheral immune cells and their HLA-G and receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence.","Objectives: Host immune responses are indispensable to combat the disease. We report the dynamics of peripheral immune cells, cytokines, and human leucocyte antigen-G (HLA-G) and its receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence. Methods: Clinical data of the patient were collected from medical records. The expressions of HLA-G and receptors ILT2, ILT4 and KIR2DL4 in peripheral immune cells were measured with flow cytometry. Results: From critical COVID-19 to the convalescent stage, early lymphopenia was improved (median: 0.6 x 10(9) L(-1) vs. 0.9 x 10(9) L(-1), P = 0.009), and an obvious fluctuation in WBC and neutrophil counts was observed. Initially, low levels of CD4(+) T cells (from 120 to 528 muL(-1)) and CD8(+) T cells (from 68 to 362 muL(-1)) gradually increased to normal levels. Meanwhile, high IL-6 (from 251.8 to 6.32 pg mL(-1)), IL-10 (from 39.53 to 5.21 pg mL(-1)) and IFN-gamma (from 13.55 to 3.16 pg mL(-1)) levels decreased, and IL-4 (from 2.36 to 3.19 pg mL(-1)) and TNF-alpha (from 2.27 to 20.2 pg mL(-1)) levels increased quickly when the viral RNA returned negative. Moreover, the percentage of HLA-G(+) T cells, B cells and monocytes follows high-low-high pattern, while the percentage of receptors ILT2-, ILT4- and KIR2DL4-expressing cells remained relatively stable. Conclusion: Our findings provide valuable information on the dynamics of early peripheral immunological responses in SARS-CoV-2 infection. CD4(+) and CD8(+) T cells, cytokines and HLA-G(+) immune cells are associated with the natural history of the critical COVID-19 patient; however, future studies are necessary.","Clin Transl Immunology","Zhang, Sheng","Gan, Jun","Chen, Bao-Guo","Zheng, Dan","Zhang, Jian-Gang","Lin, Rong-Hai","Zhou, Yi-Ping","Yang, Wei-Ying","Lin, Aifen","Yan, Wei-Hua","32399213"],"abstract":["Objectives: Host immune responses are indispensable to combat the disease. We report the dynamics of peripheral immune cells, cytokines, and human leucocyte antigen-G (HLA-G) and its receptor expressions in a patient suffering from critical COVID-19 pneumonia to convalescence. Methods: Clinical data of the patient were collected from medical records. The expressions of HLA-G and receptors ILT2, ILT4 and KIR2DL4 in peripheral immune cells were measured with flow cytometry. Results: From critical COVID-19 to the convalescent stage, early lymphopenia was improved (median: 0.6 x 10(9) L(-1) vs. 0.9 x 10(9) L(-1), P = 0.009), and an obvious fluctuation in WBC and neutrophil counts was observed. Initially, low levels of CD4(+) T cells (from 120 to 528 muL(-1)) and CD8(+) T cells (from 68 to 362 muL(-1)) gradually increased to normal levels. Meanwhile, high IL-6 (from 251.8 to 6.32 pg mL(-1)), IL-10 (from 39.53 to 5.21 pg mL(-1)) and IFN-gamma (from 13.55 to 3.16 pg mL(-1)) levels decreased, and IL-4 (from 2.36 to 3.19 pg mL(-1)) and TNF-alpha (from 2.27 to 20.2 pg mL(-1)) levels increased quickly when the viral RNA returned negative. Moreover, the percentage of HLA-G(+) T cells, B cells and monocytes follows high-low-high pattern, while the percentage of receptors ILT2-, ILT4- and KIR2DL4-expressing cells remained relatively stable. Conclusion: Our findings provide valuable information on the dynamics of early peripheral immunological responses in SARS-CoV-2 infection. CD4(+) and CD8(+) T cells, cytokines and HLA-G(+) immune cells are associated with the natural history of the critical COVID-19 patient; however, future studies are necessary."],"journal":"Clin Transl Immunology","authors":["Zhang, Sheng","Gan, Jun","Chen, Bao-Guo","Zheng, Dan","Zhang, Jian-Gang","Lin, Rong-Hai","Zhou, Yi-Ping","Yang, Wei-Ying","Lin, Aifen","Yan, Wei-Hua"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32399213","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/cti2.1128","keywords":["covid-19","hla-g","sars-cov-2","peripheral immune cells"],"locations":["neutrophil"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666714494970101760,"score":153.99939},{"pmid":32427582,"title":"Clinical and pathological investigation of severe COVID-19 patients.","text":["Clinical and pathological investigation of severe COVID-19 patients.","BACKGROUND: Severe acute respiratory coronavirus 2 (SARS-CoV-2) caused coronavirus disease 2019 (COVID-19) has become a pandemic. This study addressed the clinical and immunopathological characteristics of severe COVID-19. METHODS: Sixty-nine COVID-19 patients were classified into as severe and non-severe groups to analyze their clinical and laboratory characteristics. A panel of blood cytokines was quantified over time. Biopsy specimens from two deceased cases were obtained for immunopathological, ultrastructural, and in situ hybridization examinations. RESULTS: Circulating cytokines, including IL8, IL6, TNFalpha, IP10, MCP1, and RANTES, were significantly elevated in severe COVID-19 patients. Dynamic IL6 and IL8 were associated with disease progression. SARS-CoV-2 was demonstrated to infect type II, type I pneumocytes and endothelial cells, leading to severe lung damage through cell pyroptosis and apoptosis. In severe cases, lymphopenia, neutrophilia, depletion of CD4+ and CD8+ T lymphocytes, and massive macrophage and neutrophil infiltrates were observed in both blood and lung tissues. CONCLUSIONS: A panel of circulating cytokines could be used to predict disease deterioration and inform clinical interventions. Severe pulmonary damage was predominantly attributed to both SARS-CoV-2 caused cytopathy and immunopathologic damage. Strategies that encourage pulmonary recruitment and overactivation of inflammatory cells by suppressing cytokine storm might improve the outcomes of severe COVID-19 patients.","JCI Insight","Li, Shaohua","Jiang, Lina","Li, Xi","Lin, Fang","Wang, Yijin","Li, Boan","Jiang, Tianjun","An, Weimin","Liu, Shuhong","Liu, Hongyang","Xu, Pengfei","Zhao, Lihua","Zhang, Lixin","Mu, Jinsong","Wang, Hongwei","Kang, Jiarui","Li, Yan","Huang, Lei","Zhu, Caizhong","Zhao, Shousong","Lu, Jiangyang","Ji, Junsheng","Zhao, Jingmin","32427582"],"abstract":["BACKGROUND: Severe acute respiratory coronavirus 2 (SARS-CoV-2) caused coronavirus disease 2019 (COVID-19) has become a pandemic. This study addressed the clinical and immunopathological characteristics of severe COVID-19. METHODS: Sixty-nine COVID-19 patients were classified into as severe and non-severe groups to analyze their clinical and laboratory characteristics. A panel of blood cytokines was quantified over time. Biopsy specimens from two deceased cases were obtained for immunopathological, ultrastructural, and in situ hybridization examinations. RESULTS: Circulating cytokines, including IL8, IL6, TNFalpha, IP10, MCP1, and RANTES, were significantly elevated in severe COVID-19 patients. Dynamic IL6 and IL8 were associated with disease progression. SARS-CoV-2 was demonstrated to infect type II, type I pneumocytes and endothelial cells, leading to severe lung damage through cell pyroptosis and apoptosis. In severe cases, lymphopenia, neutrophilia, depletion of CD4+ and CD8+ T lymphocytes, and massive macrophage and neutrophil infiltrates were observed in both blood and lung tissues. CONCLUSIONS: A panel of circulating cytokines could be used to predict disease deterioration and inform clinical interventions. Severe pulmonary damage was predominantly attributed to both SARS-CoV-2 caused cytopathy and immunopathologic damage. Strategies that encourage pulmonary recruitment and overactivation of inflammatory cells by suppressing cytokine storm might improve the outcomes of severe COVID-19 patients."],"journal":"JCI Insight","authors":["Li, Shaohua","Jiang, Lina","Li, Xi","Lin, Fang","Wang, Yijin","Li, Boan","Jiang, Tianjun","An, Weimin","Liu, Shuhong","Liu, Hongyang","Xu, Pengfei","Zhao, Lihua","Zhang, Lixin","Mu, Jinsong","Wang, Hongwei","Kang, Jiarui","Li, Yan","Huang, Lei","Zhu, Caizhong","Zhao, Shousong","Lu, Jiangyang","Ji, Junsheng","Zhao, Jingmin"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32427582","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1172/jci.insight.138070","keywords":["apoptosis","infectious disease","macrophages","medical statistics","pulmonology"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667352728801640449,"score":151.10263},{"pmid":32425950,"pmcid":"PMC7205903","title":"Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).","text":["Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).","Background: The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed great threat to human health. T cells play a critical role in antiviral immunity but their numbers and functional state in COVID-19 patients remain largely unclear. Methods: We retrospectively reviewed the counts of T cells and serum cytokine concentration from data of 522 patients with laboratory-confirmed COVID-19 and 40 healthy controls. In addition, the expression of T cell exhaustion markers were measured in 14 COVID-19 cases. Results: The number of total T cells, CD4(+) and CD8(+) T cells were dramatically reduced in COVID-19 patients, especially in patients requiring Intensive Care Unit (ICU) care. Counts of total T cells, CD8(+) T cells or CD4(+) T cells lower than 800, 300, or 400/muL, respectively, were negatively correlated with patient survival. T cell numbers were negatively correlated to serum IL-6, IL-10, and TNF-alpha concentration, with patients in the disease resolution period showing reduced IL-6, IL-10, and TNF-alpha concentrations and restored T cell counts. T cells from COVID-19 patients had significantly higher levels of the exhausted marker PD-1. Increasing PD-1 and Tim-3 expression on T cells was seen as patients progressed from prodromal to overtly symptomatic stages. Conclusions: T cell counts are reduced significantly in COVID-19 patients, and the surviving T cells appear functionally exhausted. Non-ICU patients with total T cells counts lower than 800/muL may still require urgent intervention, even in the immediate absence of more severe symptoms due to a high risk for further deterioration in condition.","Front Immunol","Diao, Bo","Wang, Chenhui","Tan, Yingjun","Chen, Xiewan","Liu, Ying","Ning, Lifen","Chen, Li","Li, Min","Liu, Yueping","Wang, Gang","Yuan, Zilin","Feng, Zeqing","Zhang, Yi","Wu, Yuzhang","Chen, Yongwen","32425950"],"abstract":["Background: The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed great threat to human health. T cells play a critical role in antiviral immunity but their numbers and functional state in COVID-19 patients remain largely unclear. Methods: We retrospectively reviewed the counts of T cells and serum cytokine concentration from data of 522 patients with laboratory-confirmed COVID-19 and 40 healthy controls. In addition, the expression of T cell exhaustion markers were measured in 14 COVID-19 cases. Results: The number of total T cells, CD4(+) and CD8(+) T cells were dramatically reduced in COVID-19 patients, especially in patients requiring Intensive Care Unit (ICU) care. Counts of total T cells, CD8(+) T cells or CD4(+) T cells lower than 800, 300, or 400/muL, respectively, were negatively correlated with patient survival. T cell numbers were negatively correlated to serum IL-6, IL-10, and TNF-alpha concentration, with patients in the disease resolution period showing reduced IL-6, IL-10, and TNF-alpha concentrations and restored T cell counts. T cells from COVID-19 patients had significantly higher levels of the exhausted marker PD-1. Increasing PD-1 and Tim-3 expression on T cells was seen as patients progressed from prodromal to overtly symptomatic stages. Conclusions: T cell counts are reduced significantly in COVID-19 patients, and the surviving T cells appear functionally exhausted. Non-ICU patients with total T cells counts lower than 800/muL may still require urgent intervention, even in the immediate absence of more severe symptoms due to a high risk for further deterioration in condition."],"journal":"Front Immunol","authors":["Diao, Bo","Wang, Chenhui","Tan, Yingjun","Chen, Xiewan","Liu, Ying","Ning, Lifen","Chen, Li","Li, Min","Liu, Yueping","Wang, Gang","Yuan, Zilin","Feng, Zeqing","Zhang, Yi","Wu, Yuzhang","Chen, Yongwen"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425950","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3389/fimmu.2020.00827","keywords":["covid-19","sars- cov-2","t cell exhaustion","t cell reduction","cytokine strom"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667352728873992192,"score":149.53215}]}